Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Impact of commercial and autogenous Escherichia coli vaccine combination on broiler breeder stock performance, gross pathology, and diversity of Escherichia coli isolates

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16170%2F22%3A43880284" target="_blank" >RIV/62157124:16170/22:43880284 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/62157124:16810/22:43880284 RIV/62157124:16270/22:43880284

  • Výsledek na webu

    <a href="https://actavet.vfu.cz/media/pdf/actavet_2022091040383.pdf" target="_blank" >https://actavet.vfu.cz/media/pdf/actavet_2022091040383.pdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.2754/avb202291040383" target="_blank" >10.2754/avb202291040383</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Impact of commercial and autogenous Escherichia coli vaccine combination on broiler breeder stock performance, gross pathology, and diversity of Escherichia coli isolates

  • Popis výsledku v původním jazyce

    Avian colibacillosis is one of the main causes of economic losses in the poultry industry worldwide. Vaccination could help to prevent infection during the laying period on broiler breeder farms. Effective vaccination against avian pathogenic Escherichia coli (APEC) may be an essential step for protection of poultry flocks depending on the region where they are raised. The aim of this study was to investigate the additive protective effect of an autogenous E. coli vaccine in broiler breeders pre-vaccinated with a licensed E. coli vaccine (Poulvac (R)). Our field study was partially blinded and parallel group designed. Group 1 included 24 000 laying hens vaccinated by Poulvac (R). Group 2 comprised 12 000 laying hens vaccinated by Poulvac (R) and additionally, by an autogenous E. coli vaccine via intramuscular application before transfer. The effectiveness of vaccination in both groups was evaluated according to the results of gross pathology, bacteriology (isolation and characterization of E. coli) and utility indicators. Based on the pathology, the occurrence of E. coli polyserositis syndrome (EPS), salpingoperitonitis syndrom (SPS), and haemorrhagic septicaemia was decreased in Group 2 compared to Group 1. The difference in the occurrence of EPS (P &lt; 0.001) and SPS (P = 0.0342) was significant. The proportion of serotype O78 among E. coli isolated from Group 1 and Group 2 was also significant (P = 0.0178). The effective and multi-serotype vaccination program in order to expand heterologous protection of laying hens and combination of commercial and autogenous vaccines seems to be a promising preventive management tool.

  • Název v anglickém jazyce

    Impact of commercial and autogenous Escherichia coli vaccine combination on broiler breeder stock performance, gross pathology, and diversity of Escherichia coli isolates

  • Popis výsledku anglicky

    Avian colibacillosis is one of the main causes of economic losses in the poultry industry worldwide. Vaccination could help to prevent infection during the laying period on broiler breeder farms. Effective vaccination against avian pathogenic Escherichia coli (APEC) may be an essential step for protection of poultry flocks depending on the region where they are raised. The aim of this study was to investigate the additive protective effect of an autogenous E. coli vaccine in broiler breeders pre-vaccinated with a licensed E. coli vaccine (Poulvac (R)). Our field study was partially blinded and parallel group designed. Group 1 included 24 000 laying hens vaccinated by Poulvac (R). Group 2 comprised 12 000 laying hens vaccinated by Poulvac (R) and additionally, by an autogenous E. coli vaccine via intramuscular application before transfer. The effectiveness of vaccination in both groups was evaluated according to the results of gross pathology, bacteriology (isolation and characterization of E. coli) and utility indicators. Based on the pathology, the occurrence of E. coli polyserositis syndrome (EPS), salpingoperitonitis syndrom (SPS), and haemorrhagic septicaemia was decreased in Group 2 compared to Group 1. The difference in the occurrence of EPS (P &lt; 0.001) and SPS (P = 0.0342) was significant. The proportion of serotype O78 among E. coli isolated from Group 1 and Group 2 was also significant (P = 0.0178). The effective and multi-serotype vaccination program in order to expand heterologous protection of laying hens and combination of commercial and autogenous vaccines seems to be a promising preventive management tool.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    40301 - Veterinary science

Návaznosti výsledku

  • Projekt

    <a href="/cs/project/QK22020066" target="_blank" >QK22020066: Opatření na snižování spotřeby a racionální užití antibiotik ve výkrmu brojlerů v České republice</a><br>

  • Návaznosti

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Ostatní

  • Rok uplatnění

    2022

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Acta veterinaria Brno

  • ISSN

    0001-7213

  • e-ISSN

    1801-7576

  • Svazek periodika

    91

  • Číslo periodika v rámci svazku

    4

  • Stát vydavatele periodika

    CZ - Česká republika

  • Počet stran výsledku

    8

  • Strana od-do

    383-390

  • Kód UT WoS článku

    000880783400009

  • EID výsledku v databázi Scopus